Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention
- PMID: 2964984
- DOI: 10.1111/j.1464-5491.1988.tb00965.x
Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention
Abstract
The relationship between macrovascular disease and serum lipids, low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL), and subfraction cholesterol, and apolipoproteins has been examined in 53 female and 95 male patients with non-insulin-dependent diabetes mellitus (NIDDM). In males, those with macrovascular disease had higher serum and LDL cholesterol concentrations than those without. In females, those with macrovascular disease had higher levels of serum triglyceride, cholesterol, LDL cholesterol, as well as lower HDL, HDL2, and HDL3 cholesterol and apoprotein A-1, than those without. On multivariate analysis, LDL cholesterol was the most important association with macrovascular disease in males and apoprotein A-1 in females. In a subgroup of 36 patients, a double-blind placebo controlled study using bezafibrate or placebo, in addition to conventional oral hypoglycaemic therapy over 4 months, showed falls in serum and LDL cholesterol and in serum triglyceride and a rise in HDL cholesterol in the treated group. These changes should reduce the incidence of macrovascular disease in NIDDM and we suggest further prospective studies of such therapy in addition to conventional oral hypoglycaemic agents.
Similar articles
-
Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease.J Diabetes Complications. 2001 Sep-Oct;15(5):265-9. doi: 10.1016/s1056-8727(01)00159-3. J Diabetes Complications. 2001. PMID: 11522502
-
Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations.Am J Med. 1987 Oct;83(4):641-7. doi: 10.1016/0002-9343(87)90892-8. Am J Med. 1987. PMID: 3674053
-
Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study.Diabetes Care. 1998 Apr;21(4):641-8. doi: 10.2337/diacare.21.4.641. Diabetes Care. 1998. PMID: 9571357 Clinical Trial.
-
Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.Am J Cardiovasc Drugs. 2005;5(6):379-87. doi: 10.2165/00129784-200505060-00005. Am J Cardiovasc Drugs. 2005. PMID: 16259526 Review.
-
Plasma lipids and lipoproteins in diabetes: lessons from population-based studies.J Diabet Complications. 1990 Apr-Jun;4(2):39-41. doi: 10.1016/0891-6632(90)90026-2. J Diabet Complications. 1990. PMID: 2145294 Review. No abstract available.
Cited by
-
Treatment of diabetes: the effect on serum lipids and lipoproteins.Postgrad Med J. 1991 Oct;67(792):931-7. doi: 10.1136/pgmj.67.792.931. Postgrad Med J. 1991. PMID: 1758807 Free PMC article. Review. No abstract available.
-
The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy.J R Soc Med. 1989 Feb;82(2):93-4. doi: 10.1177/014107688908200213. J R Soc Med. 1989. PMID: 2647992 Free PMC article. Clinical Trial.
-
Specific lipid lowering therapy in the management of diabetes.Postgrad Med J. 1991 Oct;67(792):947-52. doi: 10.1136/pgmj.67.792.947. Postgrad Med J. 1991. PMID: 1758809 Free PMC article. Review. No abstract available.
-
Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.Drugs. 1996 Nov;52(5):725-53. doi: 10.2165/00003495-199652050-00008. Drugs. 1996. PMID: 9118820 Review.
-
Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).Drugs. 1990 Aug;40(2):203-19. doi: 10.2165/00003495-199040020-00003. Drugs. 1990. PMID: 2226212 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical